glp 1 and bulimia GLP-1 Agonist for Binge Eating Disorder: Evidence Safety GLP-1 Medications, Messaging, and Eating

Genomics of alternative sulfur utilization in ascomycetous yeasts

Iyer TK et al

Prolonged vomiting or diarrhoea can lead to dehydration and, in some cases, acute kidney injury (AKI)

Discussion The three trials summarized in TABLE 2 provide consistent evidence that GLP-1 RAs may be an advantageous alternative to prandial insulin as add-on therapy to basal insulin

Clinical efficacy The clinical efficacy and safety of these combination products has been established through a series of phase 3 trials (DUAL clinical program for IDegLira and LixiLan for IGlarLixi)

In addition, do not use if you have: multiple endocrine neoplasia type 2 (tumors in your glands) a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) diabetic ketoacidosis (call your doctor for treatment)